Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis - The Lancet Neurology
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies | Nature Reviews Genetics
Cells | Free Full-Text | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Cells | Free Full-Text | Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
GSK-3β controls NF-kappaB activity via IKKγ/NEMO | Scientific Reports
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Gene therapy for ALS: A review: Molecular Therapy
Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies
Cells | Free Full-Text | Hypoxia Induced NF-κB
Frontiers | Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
IJMS | Free Full-Text | Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
Recombinant Human NF-kB p65 protein (ABIN2730698)
Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis | ACS Chemical Neuroscience
Frontiers | Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
IJMS | Free Full-Text | The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Frontiers | Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers | Nature Reviews Neurology
JCM | Free Full-Text | Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Frontiers | Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
State of play in amyotrophic lateral sclerosis genetics | Nature Neuroscience
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation | Nature Reviews Drug Discovery
